z-logo
open-access-imgOpen Access
Expression, purification, crystallization and preliminary X‐ray analysis of ORF60, the small subunit (R2) of ribonucleotide reductase from Kaposi's sarcoma‐associated herpesvirus (KSHV)
Author(s) -
Gurmu Daniel,
Dahlroth SueLi,
Haas Juergen,
Nordlund Pär,
Erlandsen Heidi
Publication year - 2010
Publication title -
acta crystallographica section f
Language(s) - English
Resource type - Journals
ISSN - 1744-3091
DOI - 10.1107/s1744309110016052
Subject(s) - ribonucleotide reductase , protein subunit , ribonucleotide , biology , crystallization , microbiology and biotechnology , dna , crystallography , virology , biochemistry , gene , chemistry , nucleotide , organic chemistry
Ribonucleotide reductase (RNR) is responsible for converting ribonucleotides to deoxyribonucleotides, which are the building blocks of DNA. The enzyme is present in all life forms as well as in some large DNA viruses such as herpesviruses. The α‐herpesviruses and γ‐herpesviruses encode two class Ia RNR subunits, R1 and R2, while the β‐herpesvirus subfamily only encode an inactive R1 subunit. Here, the crystallization of the R2 subunit of RNR encoded by the ORF60 gene from the oncovirus Kaposi's sarcoma‐associated γ‐herpesvirus (KSHV) is reported. These are the first crystals of a viral R2 subunit; the use of in situ proteolysis with chymotrypsin and the addition of hexamine cobalt(III) chloride that were necessary to obtain crystals are described. Optimization of the crystallization conditions yielded crystals that diffracted to 2.0 Å resolution. The crystals belonged to space group P 2 1 , with unit‐cell parameters a = 63.9, b = 71.2, c = 71.8 Å, α = 90, β = 106.7, γ = 90°. The data set collected was 95.3% complete, with an R merge of 9.6%. There are two molecules in the asymmetric unit, corresponding to a solvent content of 43.4%.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here